Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
about
Intercellular adhesion molecules (ICAMs) and spermatogenesisVedolizumab for the treatment of ulcerative colitis and Crohn's diseaseThe clinical potential of etrolizumab in ulcerative colitis: hypes and hopesInflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsReview article: anti-adhesion therapies for inflammatory bowel diseaseAnti-α4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infectionHow Natalizumab Binds and Antagonizes 4 IntegrinsDesigning biologic selectivity for inflammatory bowel disease--role of vedolizumabRisk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's DiseaseDifferential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo.Germ cell transport across the seminiferous epithelium during spermatogenesis.The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.Vedolizumab for Crohn's disease.Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases.Prediction of clinical pharmacokinetics of AMG 181, a human anti-α 4 β 7 monoclonal antibody for treating inflammatory bowel diseasesFractalkine receptor polymorphism may not be associated with the development and clinical course of ulcerative colitisOral Serum-Derived Bovine Immunoglobulin/Protein Isolate Has Immunomodulatory Effects on the Colon of Mice that Spontaneously Develop Colitis.Oral Tolerance Induced by OVA Intake Ameliorates TNBS-Induced Colitis in Mice.Expression of Tumor-Related Macrophages and Cytokines After Surgery of Triple-Negative Breast Cancer Patients and its Implications.Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.Lung and intestine: a specific link in an ulcerative colitis rat modelPharmacology of AMG 181, a human anti-α4 β7 antibody that specifically alters trafficking of gut-homing T cells.A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitisCytotoxic-T-lymphocyte antigen 4 receptor signaling for lymphocyte adhesion is mediated by C3G and Rap1The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.Recent advances in the development of new treatments for celiac disease.Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update.Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease--an update.Translational research and efficacy of biologics in Crohn's disease: a cautionary tale.T-cell trafficking and anti-adhesion strategies in inflammatory bowel disease: current and future prospects.Role of integrin alpha4 in drug resistance of leukemiaVedolizumab: first global approval.Targeting integrins and adhesion molecules to combat inflammatory bowel disease.Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future.New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease.Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel diseaseEmerging therapeutic targets and strategies in Crohn's disease.The genetic burden of inflammatory bowel diseases: implications for the clinic?Genetic risk variants as therapeutic targets for Crohn's disease.
P2860
Q24618791-3EFBF75A-94D3-4054-864C-AE0D25789D65Q24630083-2C27201B-036C-43C2-BC0B-B3F5C51C3AC4Q26745725-C930D2D3-ADB6-4757-B789-92C95B4F47BCQ26785537-08E71A8E-74E7-4F5C-B0B2-6ED63229BFD6Q26999705-99FAE99F-39EA-4443-A5B5-858F6689C804Q27322602-DB9B714C-E0DE-48DC-91C5-229D78AFB19EQ27679979-F9F21B3C-CCB4-4DDD-9747-0D64B4A5B6EFQ28083872-2E65004B-26E4-404F-B868-E295FB499BBEQ28538974-14ADA100-6251-440A-95BD-4290AE5CF924Q30815146-9506D487-D4B8-44CD-B87C-A1945016B684Q33918591-4FB6AC2C-C158-4D9C-8DB9-644C09D58F6DQ33949950-8D688EBF-D912-468F-B20D-012C9313A588Q34326912-863F0DEC-D9D9-44A4-A618-76E92B1D0874Q34635522-C1E1CD7F-A120-48EE-BC5A-7ADC7679FA81Q35049579-0FE74B46-049A-4E01-88B4-F097E91C2AB7Q35749849-B0E17633-EE51-4334-85A4-573453433D89Q36006728-7EE1BA60-9E4B-44B6-B5E8-2A5FFEDB7F1FQ36252781-A28C51B9-BCB0-4E5C-8722-631EEAB095C0Q36462938-2C227321-BD1C-43E6-B42F-E21E4E5118CAQ36715515-527EF55C-F795-478E-8324-6B2E706CF7DDQ36763532-949F2CE2-3ABD-49CF-BD78-0F41987394A8Q36783977-BB86F810-13F3-4576-8C7E-F9CDED6C4127Q37012710-5C006609-CA65-4837-A712-63E1DEC421AEQ37643927-3E773A5C-C1D3-484A-AAB6-78AC29737659Q38016781-F0AC1FFC-15D2-4185-B4F4-0BCF272209E3Q38038684-4B94ACF1-7989-43F3-873C-B0671ED6F695Q38068963-03921211-A877-4B42-8CCC-2B0D1897C982Q38096023-0A36B199-7C0E-4166-8D95-A20AFA4F2E16Q38177338-EC472CD7-6BAC-46CD-B0A9-265EC67452FBQ38181018-DF24A1A8-D63C-4513-A723-62CCB51278DFQ38218126-C2ACF1D2-2D3A-4CB0-8840-A7E110FD18F5Q38225389-9620DB91-E2AD-4B37-8C24-390BB5190B08Q38248635-C3BA187C-D182-41F1-A41C-45BAB2761959Q38261176-21F62C2E-35DD-4CF0-A08B-344F19F93C21Q38286034-82237FCE-1400-46AA-A12D-E94AC0FD1D89Q38293802-8F650088-8CEC-4CCF-B8AA-A72C219F684EQ38660544-689F6311-F8B0-44E7-A344-BAF7826C6509Q38696392-DBF77776-B23F-4A3F-A199-0E618B9912EEQ38858574-7DAD3DB9-398C-49B7-A04A-74E9747C708DQ38915139-291738D4-E40E-45C1-BFA1-3E92DB7AEBB1
P2860
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@ast
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@en
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@nl
type
label
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@ast
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@en
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@nl
prefLabel
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@ast
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@en
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@nl
P2860
P1433
P1476
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitis.
@en
P2093
Daniel C Baumgart
Saskia Thomas
P2860
P2888
P356
10.1007/S10787-011-0104-6
P577
2011-12-20T00:00:00Z